Chairman of the Board and Chief Executive Officer
Ted Karkus has been the Chairman of the Board and the Chief Executive Officer of the Company since June 2009. Mr. Karkus was instrumental in assisting the turnaround of ID Biomedical, an influenza vaccine manufacturer, which in 2005 was sold to GlaxoSmithKline plc for over $1.4 billion. Mr. Karkus has twenty-five years of experience in securities and capital markets including two years with Fahnestock & Co. Inc., a full-service brokerage firm, where he was Senior Vice President, Director of Institutional Equities, and four years at S.G. Warburg, an investment bank, where he was an institutional equity salesman and developed a large network of institutional investors. Mr. Karkus graduated with an MBA from Columbia University Graduate School of Business in 1984 where he received Beta Gamma Sigma honors. He graduated Magna Cum Laude from Tufts University in 1981.
Chief Financial Officer
Monica Brady has served as our Chief Financial Officer since January 16, 2019. Prior to serving as our Chief Financial Officer, Ms. Brady served as our Chief Accounting Officer beginning September 2017 and our Director of Finance from 2009 to September 2017.
Chief Operating Officer, ProPhase Diagnostics, lab processing division of the company
Steve Kamalic serves as the Chief Operating Officer at ProPhase Diagnostics. Mr. Kamalic holds an AAS in medical technology and a BS in Health Administration. Prior to joining ProPhase Diagnostics, Steve Kamalic served as Chief Operating Officer and Sales Director at Acupath Laboratories. He oversaw a laboratory business that grew to $160M in annual revenues. Mr. Kamalic has worked at several startups and has a vision for growth and expansion.